CREDIT AGREEMENT dated as of March 11, 2014 among JLL/DELTA DUTCH NEWCO B.V.,Credit Agreement • September 3rd, 2015 • Patheon Holdings Cooperatief U.A. • Pharmaceutical preparations • New York
This CREDIT AGREEMENT is entered into as of March 11, 2014 among the following: (i) JLL/Delta Dutch Newco B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) incorporated under the laws of the Netherlands, as a borrower (the “Parent Borrower”); (ii) Patheon Pharmaceuticals Inc., a Delaware corporation (“PPUS”), Banner Pharmacaps Inc., a Delaware corporation (“Banner”) and DPI Newco LLC, a Delaware limited liability company (“DPI Newco”, and together with PPUS and Banner, the “US Borrowers”), Patheon UK Limited, a limited liability company incorporated under the laws of England and Wales (the “UK Borrower”), Patheon Inc., a company with limited liability incorporated under the laws of Canada (the “Canadian Borrower”), DSM Fine Chemicals Austria Nfg GmbH & CoKG, a limited partnership with an Austrian company with limited liability as general partner incorporated under the laws of Austria (the “Austrian Borrower”) and Patheon Puerto Rico,
EMPLOYMENT AGREEMENTEmployment Agreement • September 3rd, 2015 • Patheon Holdings Cooperatief U.A. • Pharmaceutical preparations • North Carolina
This Employment Agreement (the “Agreement”) is made as of May 9, 2011 (the “Effective Date”), between Patheon Pharmaceuticals Services Inc. (the “Company”) and Michael Lytton (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • September 3rd, 2015 • Patheon Holdings Cooperatief U.A. • Pharmaceutical preparations • New York
This Amended and Restated Employment Agreement (“Agreement”), dated as of the date of last signature below and effective as of February 7, 2011 (“Effective Date”), is by and between Patheon Pharmaceutical Services Inc. (the “Company”) and James Mullen (“Executive”).
May 19, 2014 PRIVATE AND CONFIDENTIAL Stuart Grant Waxhaw, NC 28173 RE: Amendment to Employment Contract Dear Stuart:Private and Confidential • September 3rd, 2015 • Patheon Holdings Cooperatief U.A. • Pharmaceutical preparations
Further to our discussions, this letter (the “Letter”), effective as of June 9, 2014 (the “Amendment Effective Date”), confirms that Patheon Pharmaceutical Services inc. (the “Company”), has agreed to increase your base salary in your current role of Executive Vice President, Chief Financial Officer, and has further agreed to provide you with the equity grant described below. Once signed, this Letter will serve as the first amendment to the Employment Agreement between you and the Company dated January 25, 2011 (the “Employment Agreement”). Any terms used in this Letter that are not defined herein have the definition ascribed to them in the Employment Agreement.
May 19, 2014 PRIVATE AND CONFIDENTIAL Harry Gill 12321 Angel Falls Rd. Raleigh, NC 27614 RE: Amendment to Employment Contract Dear Harry:Private and Confidential • September 3rd, 2015 • Patheon Holdings Cooperatief U.A. • Pharmaceutical preparations
Further to our discussions, this letter (the “Letter”), effective as of June 9, 2014 (the “Amendment Effective Date”), confirms that Patheon Pharmaceutical Services Inc. (the “Company”), has agreed to increase your base salary in your current role of Senior Vice President, Quality and Continuous Improvement, and has further agreed to provide you with the equity grant described below. Once signed, this Letter will serve as the third amendment to the Employment Agreement between you and the Company dated April 25, 2010, as amended by the Amendment Letter dated September 11, 2012 and the Second Amendment Letter dated June 3, 2013 (collectively, the “Employment Agreement”). Any terms used in this Letter that are not defined herein have the definition ascribed to them in the Employment Agreement.
